Ibandronate Sodium

Product Description

It is a nitrogen-containing bisphosphonate in the same class as alendronate and risedronate. Our firm is enlisted as one of the renowned name in offering our clients Ibandronate Sodium. This compound inhibits osteoclast-mediated bone resorption. It prevents the breakdown of bone by bone cells called osteoclasts. This drug is indicated for the treatment and prevention of osteoporosis in postmenopausal women. Ibandronate Sodium inhibits osteoclast activity and reduces bone resorption and turnover. It reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass.

 

Features:

Product Name : Ibandronate Sodium
Chemical Names : Ibandronate sodium monohydrate; 138926-19-9; IBANDRONATE SODIUM; Ibandronate sodium hydrate; Bondronat; Boniva; Destara; Bondronat (TN); Bonviva (TN); Boniva (TN); Bondenza; Ibandronate sodium hydrate (JAN)
Molecular Formula : C₉H₂₄NNaO₈P₂
Molecular Weight : 359.227 g/mol
IUPAC Name : sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate;hydrate
CAS Number : 138926-19-9
Parent Compound : Ibandronic acid (CID 60852)